High-performance liquid chromatographic assay for mitoxantrone in plasma using electrochemical detection

This publication has 13 references indexed in Scilit:

• Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors
  Investigational New Drugs, 1986
• Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Application of Electrochemical Detection for the Quantitation of 1, 4-Dihydroxy-5, 8-Bis-[2-(2-Hydroxyethyl) Aminoethylamino]-9,10-Anthracenedione Following Liquid Chromatography
  Analytical Letters, 1983
• Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone
  Journal of Chromatography B: Biomedical Sciences and Applications, 1982
• Pharmacology of mitoxantrone in cancer patients
  Cancer Chemotherapy and Pharmacology, 1982
• Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids
  Biochemical Pharmacology, 1981
• Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug
  Cancer Chemotherapy and Pharmacology, 1980
• Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline Antibiotics
  Journal of Pharmaceutical Sciences, 1979